Kamil Ali-Jackson

Companies

• RIGEL PHARMACEUTICALS INCBoard member Dec 17, 2021 to now¹
• PDS Biotechnology CorpBoard member Feb 24, 2020 to now²
• Aclaris Therapeutics, Inc.General counsel Oct 6, 2015 to Jan 5, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAclaris Therapeutics, Inc. ACRS160,214 shares⁴$525.5K at $3.28Jan 3, 2022
• RPRIGEL PHARMACEUTICALS INC RIGL10,125 shares⁵$478.4K at $47.25Jun 22, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 22, 2026Sold 2,500 shares at $35.00 of RIGEL PHARMACEUTICALS INC⁵
• May 26, 2026Sold 2,500 shares at $29.17 of RIGEL PHARMACEUTICALS INC⁶
• May 15, 2026Granted 5,750 shares of RIGEL PHARMACEUTICALS INC⁷
• May 23, 2025Granted 2,500 shares of RIGEL PHARMACEUTICALS INC⁸
• May 25, 2024Granted 25,000 shares of RIGEL PHARMACEUTICALS INC⁹
• May 26, 2023Granted 25,000 shares of RIGEL PHARMACEUTICALS INC¹⁰
• May 20, 2022Granted 18,750 shares of RIGEL PHARMACEUTICALS INC¹¹
• Jan 3, 2022Exercised options 7,100 shares of Aclaris Therapeutics, Inc.⁴
• Jan 3, 2022Exercised options 6,638 shares of Aclaris Therapeutics, Inc.⁴
• Jan 3, 2022Exercised options 27,905 shares of Aclaris Therapeutics, Inc.⁴
• Jan 3, 2022Exercised options 3,875 shares of Aclaris Therapeutics, Inc.⁴
• Mar 11, 2021Gift 7,500 shares of Aclaris Therapeutics, Inc.¹²